mHealth strategies to improve pharmacologic adherence in type 2 diabetes mellitus patients: systematic review
[Abstract] To perform a systematic review of studies assessing the impact of mHealth on treatment adherence in diabetes mellitus type II patients, describe target populations, and assess impact on adherence according to the approach and type of intervention implemented. A systematic review was car...
| Autores: | , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2022 |
| País: | España |
| Institución: | Conselleria de Salut i Consum del Govern de les Illes Balears |
| Repositorio: | Docusalut |
| Idioma: | inglés |
| OAI Identifier: | oai:docusalut.com:20.500.13003/18858 |
| Acceso en línea: | https://hdl.handle.net/20.500.13003/18858 |
| Access Level: | acceso abierto |
| Palabra clave: | Diabetes Mellitus, Type 2 Text Messaging Spain Medication Adherence Telemedicine Humans Mobile Applications Cumplimiento de la Medicación Humanos Telemedicina Diabetes Mellitus Tipo 2 Aplicaciones Móviles Envío de Mensajes de Texto España |
| Sumario: | [Abstract] To perform a systematic review of studies assessing the impact of mHealth on treatment adherence in diabetes mellitus type II patients, describe target populations, and assess impact on adherence according to the approach and type of intervention implemented. A systematic review was carried out based on a literature search on scientific databases (Medline, Embase, Web of Science and Google Scholar) to identify clinical trials or quasi-experimental studies published between 2011 and 2021 assessing the impact of mHealth strategies on adherence to drug therapy in diabetes mellitus type II patients. A bias analysis was carried out of the studies identified based on risk-ofbias 2 and risk-of-bias in nonrandomized studies of interventions criteria. Of the 120 studies retrieved, eight were included in the systematic review. The strategies identified included the use of medication reminders or educational notes sent via text messages; electronic dispensing systems; phone calls; automated response systems; and mobile applications. The impact of each strategy on adherence to drug therapy was variable, and positive results were obtained with the electronic dispensing system when used in combination with text messages, phone calls or mobile applications. Interventions were behavioral and/or educational. Inclusion criteria were homogeneous, with study patients having similar mean age, but with heterogeneous or unknown socioeconomic and educational level. Bias analysis raised some concerns in the totality of the studies included. The heterogeneity of results prevents firm conclusions from being drawn about the mHealth strategy that best improves adherence of diabetes mellitus type II patients to drug therapy. In most studies, patients older than 65 years are underrepresented, despite them accounting for 21% of diabetic patients in Spain. Interventions were behavioral and/or educational and are aligned with other publications on Telemedicine interventions. Further studies are needed to identify the most effective mHealth strategies in improving treatment adherence in diabetes mellitus type II patients. |
|---|